1. Academic Validation
  2. Synthesis and biological evaluation of cyclic sulfamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors

Synthesis and biological evaluation of cyclic sulfamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors

  • ACS Med Chem Lett. 2012 Jan 17;3(2):88-93. doi: 10.1021/ml200226x.
Se Hoan Kim 1 Ju Han Bok 2 Jae Hong Lee 1 Il Hyang Kim 1 Sung Wook Kwon 1 Gui Bin Lee 2 Seung Kyu Kang 2 Ji Seon Park 2 Won Hoon Jung 2 Hee Yeon Kim 2 Sang Dal Rhee 2 Sung Hoon Ahn 2 Myung Ae Bae 2 Deok Chan Ha 3 Ki Young Kim 2 Jin Hee Ahn 2
Affiliations

Affiliations

  • 1 Bio-Organic Science Division, Korea Research Institute of Chemical Technology , Yuseong-Gu, Daejeon, 305-600, Korea ; Department of Chemistry, Korea University , Sungbuk-gu, Seoul 136-701, Korea.
  • 2 Bio-Organic Science Division, Korea Research Institute of Chemical Technology , Yuseong-Gu, Daejeon, 305-600, Korea.
  • 3 Department of Chemistry, Korea University , Sungbuk-gu, Seoul 136-701, Korea.
Abstract

A new series of cyclic sulfamide derivatives were synthesized and evaluated for their ability to inhibit 11β-HSD1. Among this series, 18e showed good in vitro activity toward human 11β-HSD1, selectivity against 11β-HSD2, microsomal stability, and pharmacokinetic and safety profiles (hERG, CYP, and acute toxicity). Additionally, 18e exhibited good in vivo efficacy in rat and monkey models.

Keywords

11β-hydroxysteroid dehydrogenase type 1; adamantyl group; antidiabetic agents; cyclic sulfamide; diabetes.

Figures